News

In preparation for U.S. News World & Report’s annual best ophthalmic hospitals for 2015-which will be announced next month-we have compiled the news site’s list of the top programs from last year. These 10 hospitals were coined the best for difficult cases and procedures by at least 5% of ophthalmology respondents to U.S. News’ surveys in 2012, 2013, and 2014.

The European Medicines Agency (EMA) has granted orphan drug designation to ISTH0036, a locked nucleic acid-modified antisense oligonucleotide under development by Munich-based Isarna Therapeutics, for the prevention of scarring after glaucoma filtration surgery (GFS).

Targeting the blood-vessel-growth protein angiopoietin-like 4 (ANGPTL4) along with anti-vascular endothelial growth factor (VEGF) therapy could increase the effectiveness of treatments for the prevention of proliferative diabetic retinopathy (PDR), according to researchers at The Johns Hopkins University and the University of Maryland.

As staff members develop in new roles, managers should coach and counsel them in the direction where they are thinking and making decisions in a global manner, not an individual manner.

The costs associated with medications for patients with glaucoma continue to have a significant effect on adherence. Making a switch from branded to generic drugs may make a difference for some patients in certain cases.

Take-home message: When considering IOL implantation options when there is a lack of capsular support, cataract surgeons should use the approach with which they are most comfortable. They should also continue to learn about new available techniques.

Multifocal IOLs with a trifocal diffractive optic design are available outside of the United States. They provide good visual acuity for distance, intermediate, and near and appear to provide slightly better intermediate vision than bifocal diffractive multifocal IOLs.